What are the Historical Developments and Current Growth Metrics of the Safety Syringe Market?
The safety syringe market has seen considerable growth due to a variety of factors.
• In the past few years, the safety syringe market has seen a substantial increase in size. The market, which was valued at $8.95 billion in 2024, is projected to reach $9.76 billion in 2025, showcasing a compound annual growth rate (CAGR) of 9.1%.
Factors contributing to this growth in the historic period include concerns over needlestick injuries, regulatory requirements, broader acceptance of safety procedures, a rise in cases of blood-borne diseases, and the expansion of healthcare infrastructure.
What is the Forecasted Market Size and CAGR for the Safety Syringe Market?
The safety syringe market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of safety syringes is predicted to witness significant expansion in the upcoming years, reaching a valuation of $13.78 billion by 2029, with a compound annual growth rate (CAGR) of 9.0%.
The predicted growth during the forecast period can be associated with vaccination campaigns, an increasing aging population, greater attention towards preventive healthcare, a growing biopharmaceutical sector, as well as advancements in material sciences. Noteworthy trends during the forecast period comprise of accelerated technological innovations, a focus on environmentally-friendly solutions, incorporation of telehealth, customized solutions for specific therapeutics, and improved emergency readiness and response.
What Key Factors and Trends Are Driving The Growth Safety Syringe Market?
The upswing in blood-borne infections is set to fuel the expansion of the safety syringe market. Infections transferred via blood, which can include diseases caused by bacteria, viruses or parasites, are categorized as blood-borne diseases. Safety syringes are employed as a protective step to safeguard healthcare employees and patients against the hazards of blood-borne infections. These syringes reduce the chances of inadvertent exposure and encourage superior practices in medical processes. To illustrate, the World Health Organization, a Switzerland-based international agency, stated in April 2024 that around 254 million individuals had chronic hepatitis B in 2022, with 1.2 million new cases being reported every year. This disease resulted in nearly 1.1 million fatalities in the same year, primarily due to cirrhosis and hepatocellular carcinoma (primary liver cancer). It also estimated that about 50 million individuals globally have chronic hepatitis C, with roughly 1 million new infections reported each year. In 2022, hepatitis C was responsible for nearly 242,000 deaths, primarily due to cirrhosis and hepatocellular carcinoma (primary liver cancer). Consequently, the escalating instances of blood-borne infections are propelling the safety syringe market's growth.
What Are The Market Segments In The Safety Syringe Market?
The safety syringe market covered in this report is segmented –
1) By Product: Retractable Safety Syringes, Non Retractable Safety Syringes
2) By Therapy: Insulin, Glucagon-like peptide-I (CLP-I), Tuberculosis, Growth Hormones
3) By Application: Subcutaneous, Intramuscular
4) By End-user: Hospitals, Ambulatory Surgical Centers, Long-term Care Facilities, Specialty Clinics, Other End Users
Subsegments:
1) By Retractable Safety Syringes: Automatic Retractable Safety Syringes, Manual Retractable Safety Syringes
2) By Non-Retractable Safety Syringes: Fixed Needle Safety Syringes, Shielded Needle Safety Syringes
Pre-Book The Safety Syringe Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Safety Syringe Industry?
Significant players in the safety syringe market, such as Becton, Dickinson, and Company, are driving innovation by creating new products like glass vaccine syringes to maintain a strong competitive presence. These specific syringes, made from glass, provide a hygienic and reusable solution for medication delivery. In September 2022, the US firm unveiled the BD Effivax Glass Prefillable Syringe. These distinctively engineered syringes bolster the safety and dependability of drug distribution systems, primarily vaccines. Their design ensures precise medication dosage, tackling potential issues of contamination and product compromise during the process of preparation and administration. By refining manufacturing and design methods, these syringes curtail the hazards linked with conventional vial procedures, thereby playing a crucial role in safeguarding patients during vaccine administration.
Who Are the Key Players In The Safety Syringe Market?
Major companies operating in the safety syringe market report are:
• Cardinal Health Inc.
• Retractable Technologies Inc.
• Thermo Fisher Scientific Inc.
• Medtronic plc
• Novo Nordisk A/s
• Becton
• Dickinson and Company
• Baxter International Inc.
• Boston Scientific Corporation
• Medline Industries LP
• Terumo Corporation
• B. Braun Melsungen AG
• West Pharmaceutical Services Inc.
• Fresenius Kabi AG
• Nemera
• Smiths Medical International Ltd.
• Nipro Medical Corporation
• Henke-Sass Wolf GmbH
• Revolutions Medical Inc.
• Sol-Millennium Inc.
• UltiMed Inc.
• Unilife Corporation
• AdvaCare Pharma
• Axol Bio Corporation
• Vita Needle Company
• Numedico Technologies Pty Ltd.
• Duopross Meditech Corporation
• DMC Medical Ltd.
• Guangdong Haiou Medical Apparatus Co. Ltd.
• Kendall Healthcare Group Ltd.
What Are The Regional Insights Into The Safety Syringe Market?
North America was the largest region in the safety syringes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the safety syringe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
